preview

Polycystic Ovary Syndrome

Better Essays

Polycystic ovary syndrome is an endocrine disorder that affects at least 10% of women living in the United States. Insulin Resistance plays a large part in fertility for women who have polycystic ovary syndrome. Myo-Inositol improves fertility, and alleviates many of the symptoms associated with polycystic ovary syndrome and insulin resistance. Case findings of women with polycystic ovary syndrome were first documented in 1935 by American gynecologists Irving F. Stein, Sr., and Michael L. Leventhal (Hoyt and Schmidt 156). For many years, polycystic ovary syndrome was called the “Stein-Leventhal syndrome”. Once insulin resistance was added to the diagnosis of polycystic ovary syndrome the name of the syndrome then changed to “Syndrome X” (Bhathena 106). Polycystic ovary syndrome is a condition that affects many different parts of the body, not just the ovaries. The list of ailments associated with polycystic ovary syndrome is long, ranging from skin tags, dark skin patches, and hirsutism (male patterned hair growth) to liver disease, obesity, and insulin resistance. The symptoms that contribute to infertility are irregular menstrual cycles, an excess of androgens, and chronic anovulation (Genazzani, Lanzoni and Riccieri 139). Polycystic ovary syndrome is shortened to its acronym of PCOS by the medical community and the women who have been diagnosed with it. Polycystic ovary syndrome is predominant among reproductive women between the ages of 12 and 45 (Banning 635).

Get Access